No abstract available
Keywords:
DMARDs; co-morbidity; drug toxicity; methotrexate; rheumatic disease; safe prescribing; shared care; treatment monitoring.
MeSH terms
-
Antirheumatic Agents / therapeutic use*
-
Drug Monitoring
-
Drug Prescriptions
-
Humans
-
Rheumatic Diseases / drug therapy*